X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...   Read More

What’s driving insurance premium increases? Hint: It’s not prescription drugs

By Allyson Funk  |    August 2, 2016
A new analysis from Avalere Health looks at 2017 proposed health insurance premium increases. As in 2016, insurers’ own data point to outpatient spending as the largest expected driver of premium...   Read More

ICYMI: More attention to adequacy of health insurance coverage

By Allyson Funk  |    July 8, 2016
On AccessBetterCoverage.org, we’ve been highlighting the growing challenges of insurance benefit design and the impact of high deductibles and out-of-pocket costs on patients. Last week in The...   Read More

Burden on patients: Insurance benefit design’s impact on patient access to medicines

By Allyson Funk  |    June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...   Read More

Burden on patients: Access to medicines in health insurance exchange plans

By Allyson Funk  |    June 23, 2016
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...   Read More

Empowering consumers and improving access to out-of-pocket cost information

By Allyson Funk  |    June 16, 2016
A well-informed consumer is an engaged and empowered patient. One policy solution for delivering innovative treatments to patients is to engage and empower consumers by making more information...   Read More

Many consumers still face confusion around health insurance coverage

By Rebecca Davison  |    May 25, 2016
Consumers need to be engaged and empowered when making decisions about their health coverage. Two recent studies suggest more can be done to help consumers sort through their health insurance...   Read More

A state-by-state look at coverage and access hurdles in 2016 exchange plans

By Rebecca Davison  |    May 6, 2016
We frequently talk about access barriers patients with health insurance exchange plans face, including two recent studies from Avalere Health and Harvard University Center for Health Law and...   Read More

New Avalere study: Health plan formularies continue to suggest bias against individuals with certain health conditions

By Karyn Schwartz  |    April 19, 2016
Despite warnings from the Centers for Medicare & Medicaid Services (CMS) that requiring high cost sharing for all or most medications to treat a condition may be discriminatory, new data from...   Read More

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

By Holly Campbell  |    April 14, 2016
Despite misleading claims made about spending on new innovative treatments and cures, another report confirms how the competitive biopharmaceutical market works to control costs. Net prices for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates